IVD Translation Services

IVD translation is the translation of content used by in vitro diagnostic companies across markets. Typical content includes IFUs, eIFUs, labels, packaging, intended purpose statements, specimen handling instructions, warnings, precautions, performance evaluation content, technical documentation, regulatory submissions, software UI strings, result wording, safety communications, training materials and distributor content. The objective is accurate, complete and source-faithful translation that reflects approved source content, diagnostic terminology and IVDR language. AbroadLink provides IVD translation through ISO-based workflows with qualified linguists, controlled terminology and risk-based workflow selection matched to content profile.

IVDR translation services cover the translation of content linked to the EU In Vitro Diagnostic Regulation, including technical documentation, performance evaluation content, IFUs, labelling, eIFUs, intended purpose statements, software content, regulatory submissions and authority-facing material. AbroadLink supports IVDR translation services with qualified IVD linguists, controlled terminology and risk-based workflow selection. AbroadLink does not decide IVDR compliance, device classification, performance adequacy, notified body acceptance, CE marking or product approval. Those decisions remain the responsibility of your regulatory, QARA, performance evaluation and certification stakeholders.

IVD labelling translation is the translation of content that appears on IVD labels, packaging and related artwork, including product names, intended purpose elements, warnings, precautions, symbols, UDI elements and required regulatory information. It is layout-aware, since label space, character limits, symbol references and artwork constraints all influence wording. AbroadLink supports IVD labelling translation with controlled terminology, IVDR references and review depth matched to risk. Final approval of label content remains with your regulatory, QARA, packaging, artwork and quality teams, since labelling decisions fall outside the scope of language services.

General medical device translation covers a broad range of devices under MDR and other frameworks. IVD translation focuses on devices governed by IVDR and similar regulations, where content reflects laboratory workflows, specimen handling, analytical and clinical performance, intended user (professional or self-test), result interpretation and IVD software. Terminology is more diagnostic and laboratory-oriented, and software localization plays a stronger role in many IVD products. AbroadLink supports both workflows but adjusts process, review depth, terminology setup and reviewer profile to match IVD subject matter, IVDR documentation and laboratory-context needs.

No. Lower-risk workflows do not lower the translation accuracy requirement. The objective remains accurate, complete and source-faithful translation for every IVD content type, including lower-risk internal drafts, administrative documents, repeated content and distributor support material. What changes between workflows is the depth of review, revision steps, terminology controls and validation activities applied to manage residual translation risk. A lower-risk workflow may be appropriate when content type, intended user, IVD context, regulatory context, target markets and your internal controls support that decision, not because accuracy expectations are reduced.

AbroadLink reviews IVD type, content profile, intended user, regulatory context, target markets and software exposure before proposing a workflow. IFUs, labelling, intended purpose, specimen instructions, warnings, performance evaluation content, software UI, eIFUs, safety communications and authority-facing content may justify ISO 17100 translation services with independent revision. Internal drafts, repeated content and lower-risk distributor support may justify a lighter workflow. AbroadLink supports workflow selection, but IVDR compliance, performance evaluation, software validation, notified body strategy and CE marking remain with your internal teams. See Linguistic Risk Assessment for more.

AI-assisted workflows can support IVDR translation services in controlled scenarios, typically as a pre-translation step followed by qualified human review and validation. AbroadLink offers controlled AI workflows through aiHubLink, using client terminology, IVDR references and ISO-based processes. For IFUs, labelling, intended purpose, specimen instructions, warnings, performance evaluation content, technical documentation, software UI, eIFUs, safety communications and authority-facing content, AI should only be used with clear governance, qualified review and traceability. AI does not replace IVD-aware linguists, independent revision or internal regulatory, QARA, software and performance evaluation review steps.

No. IVD translation, IVDR translation services, in vitro diagnostic translation, IVD labelling translation, ISO 17100 translation services, AI-assisted workflows, certificates and risk-based workflow support do not guarantee IVDR compliance, device classification adequacy, performance acceptance, software validation, notified body acceptance, competent authority acceptance, CE marking, product approval, safe use, correct use, market access or business outcomes. AbroadLink provides language services and translation workflow support. Decisions about IVDR compliance, performance evaluation, software validation, usability evaluation, certification strategy and final content release remain with your regulatory, QARA, clinical, software and quality stakeholders.